Boyds has bolstered its service offering with the launch of a new in-house regulatory operations service that will enable the company to support the full lifecycle of its clients’ drug development projects.

The new service, which has been developed in direct response to growing client demand, will involve the planning, coordination, and execution of all tasks relating to the development, submission, and maintenance of regulatory documents necessary for the approval and post-approval lifecycle of drugs, medical devices, and other healthcare products.

To lead the publishing division, Boyds has appointed experienced regulatory operations and publishing professional Michelle Hackney, who will support the Regulatory Operations team headed up by Vice President and Head of US Regulatory Affairs, Katy Rudnick.

Boyds has also invested in industry-leading regulatory information management software, LORENZ docuBridge, which provides a range of features including regulatory document management, content validation, and deployment of electronic submissions.